Viewing Study NCT03965533


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-02-18 @ 8:42 PM
Study NCT ID: NCT03965533
Status: COMPLETED
Last Update Posted: 2020-11-18
First Post: 2019-05-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Japanese, Caucasian, pharmacokinetics, pharmacodynamics, GSK2831781, lymphocyte activation gene-3 View